Verastem (VSTM) Change in Account Payables (2011 - 2026)
Verastem's quarterly Change in Account Payables came in at -$2.8 million in Q1 2026, down 189.69% year-on-year from $3.2 million in Q1 2025, and down 172.9% quarter-over-quarter from $3.9 million in Q4 2025.
Verastem has reported Change in Account Payables for 16 years, with the latest figure at -$2.8 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 189.69% year-over-year to -$2.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 1061.2% YoY), and the FY2025 full-year result was $8.4 million, up 366.69% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.8 million, down from $3.9 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.9 million in Q4 2025, with the low at -$2.8 million in Q1 2026.
- Average Change in Account Payables over 5 years is $429411.8, with a median of $92000.0 recorded in 2022.
- Peak annual rise in Change in Account Payables reached 13150.0% in 2024, while the deepest fall reached 450.55% in 2024.
- Tracing VSTM's Change in Account Payables over 5 years: stood at -$458000.0 in 2022, then soared by 551.09% to $2.1 million in 2023, then plunged by 119.94% to -$412000.0 in 2024, then surged by 1047.57% to $3.9 million in 2025, then plunged by 172.9% to -$2.8 million in 2026.
- The last three Change in Account Payables figures came in at -$2.8 million (Q1 2026), $3.9 million (Q4 2025), and $497000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | -2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.85 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 497,000.00 |
| Sep 30, 2025 | 497,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | -412,000.00 |
| Dec 31, 2024 | -412,000.00 |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -771,000.00 |
| Jun 30, 2024 | -771,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 639,000.00 |
| Sep 30, 2023 | 639,000.00 |
| Jun 30, 2023 | -424,000.00 |
| Jun 30, 2023 | -424,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | -458,000.00 |
| Dec 31, 2022 | -458,000.00 |
| Sep 30, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | -688,000.00 |
| Jun 30, 2022 | -688,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 1.66 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | -754,000.00 |
| Sep 30, 2021 | -754,000.00 |
| Jun 30, 2021 | -1.06 Mn |
| Jun 30, 2021 | -1.06 Mn |
| Mar 31, 2021 | 774,000.00 |
| Mar 31, 2021 | 774,000.00 |
| Dec 31, 2020 | -3.00 Mn |
| Dec 31, 2020 | -3.00 Mn |
| Sep 30, 2020 | 2.44 Mn |
| Sep 30, 2020 | 2.44 Mn |
| Jun 30, 2020 | -4.88 Mn |
| Jun 30, 2020 | -4.88 Mn |
| Mar 31, 2020 | -2.54 Mn |
| Mar 31, 2020 | -2.54 Mn |
| Dec 31, 2019 | 813,000.00 |
| Dec 31, 2019 | 813,000.00 |
| Sep 30, 2019 | -2.69 Mn |
| Sep 30, 2019 | -2.69 Mn |
| Jun 30, 2019 | 2.94 Mn |
| Jun 30, 2019 | 2.94 Mn |
| Mar 31, 2019 | -1.66 Mn |
| Mar 31, 2019 | -1.66 Mn |
| Dec 31, 2018 | -1.06 Mn |
| Dec 31, 2018 | -1.06 Mn |
| Sep 30, 2018 | 3.54 Mn |
| Sep 30, 2018 | 3.54 Mn |
| Jun 30, 2018 | 642,000.00 |
| Jun 30, 2018 | 642,000.00 |
| Mar 31, 2018 | -2.08 Mn |
| Mar 31, 2018 | -2.08 Mn |
| Dec 31, 2017 | 1.78 Mn |
| Dec 31, 2017 | 1.78 Mn |
| Sep 30, 2017 | 538,000.00 |
| Sep 30, 2017 | 538,000.00 |
| Jun 30, 2017 | -1.86 Mn |
| Jun 30, 2017 | -1.86 Mn |
| Mar 31, 2017 | 4.59 Mn |
| Mar 31, 2017 | 4.59 Mn |
| Dec 31, 2016 | 2.13 Mn |
| Dec 31, 2016 | 2.13 Mn |
| Sep 30, 2016 | -148,000.00 |
| Sep 30, 2016 | -148,000.00 |
| Jun 30, 2016 | -485,000.00 |
| Jun 30, 2016 | -485,000.00 |
| Mar 31, 2016 | -1.35 Mn |
| Mar 31, 2016 | -1.35 Mn |
| Dec 31, 2015 | 303,000.00 |
| Dec 31, 2015 | 303,000.00 |
| Sep 30, 2015 | 618,000.00 |
| Sep 30, 2015 | 618,000.00 |
| Jun 30, 2015 | -949,000.00 |
| Jun 30, 2015 | -949,000.00 |
| Mar 31, 2015 | 891,000.00 |
| Mar 31, 2015 | 891,000.00 |
| Dec 31, 2014 | 240,000.00 |
| Dec 31, 2014 | 240,000.00 |
| Sep 30, 2014 | 234,000.00 |
| Sep 30, 2014 | 234,000.00 |
| Jun 30, 2014 | 58,000.00 |
| Jun 30, 2014 | 58,000.00 |
| Mar 31, 2014 | -245,000.00 |
| Mar 31, 2014 | -245,000.00 |
| Dec 31, 2013 | 924,000.00 |
| Dec 31, 2013 | 924,000.00 |
| Sep 30, 2013 | -198,000.00 |
| Sep 30, 2013 | -198,000.00 |
| Jun 30, 2013 | 108,000.00 |
| Jun 30, 2013 | 108,000.00 |
| Mar 31, 2013 | 78,000.00 |
| Mar 31, 2013 | 78,000.00 |
| Dec 31, 2012 | 111,000.00 |
| Dec 31, 2012 | 111,000.00 |
| Sep 30, 2012 | -713,000.00 |
| Sep 30, 2012 | -713,000.00 |
| Jun 30, 2012 | 514,000.00 |
| Jun 30, 2012 | 514,000.00 |
| Mar 31, 2012 | -337,000.00 |
| Mar 31, 2012 | -337,000.00 |
| Dec 31, 2011 | 1.03 Mn |
| Dec 31, 2011 | 1.03 Mn |
| Sep 30, 2011 | 33,000.00 |
| Sep 30, 2011 | 33,000.00 |
| Jun 30, 2011 | 800,000.00 |
| Jun 30, 2011 | 800,000.00 |
| Mar 31, 2011 | 134,000.00 |
| Mar 31, 2011 | 134,000.00 |